Tryout three mindfulness mediation exercises to relieve stress, help manage pain and improve quality of life.

Transcript of Presentation: (00:00:01): [Jordan Sexton]: Introduction. Good morning and good afternoon. Welcome to the workshop, Men's Sexual Health after Transplant. My name is Jordan Sexton and I will be

Pain with sex and a decreased desire for sex are common in women after cancer treatment. This presentation explains how the sexual response cycle works, medical interventions you can use to address genital health problems after transplant or CAR T-cell therapy, and other strategies you can use to regain intimacy with your partne

La neuropatía (daño a los nervios) es común después de un trasplante de células madre. Obtenga información sobre los diferentes tipos de neuropatías que pueden desarrollarse, los síntomas comunes, cómo se diagnostican las neuropatías y las terapias que se utilizan para tratarla.

Many bone marrow/stem cell transplant patients experience neuropathy (nerve pain) after transplant. This presentation describes the various types of neuropathy patients may experience and reviews popular treatment options.

Maintenance therapy after a stem cell transplant is used to decrease early death, increase time to progression and improve the quality of life in patients with multiple myeloma. Dr. Callander provides an overview of the history of maintenance therapy and discusses the new and exciting treatment options available. She also delves into potential future therapies that are currently under study.

Chronic graft-versus-host disease (GVHD) is a common complication after a transplant using donor stem cells (allogeneic transplant) that target many organs, including the lungs. Learn who’s at risk of developing chronic GVHD in the lungs, how it affects breathing and therapies available to treat it.

Graft-versus-host disease (GVHD) is a common complication after a stem cell transplant. Extracorporeal photopheresis (ECP) can be an effective treatment for certain types of GVHD. This presentation explains how ECP works and its potential benefits for patients with significant GVHD.

Graft-versus-host disease (GVHD) is a common complication after a bone marrow/stem cell transplant using donor cells (allogeneic transplant). This presentation will discuss current techniques to prevent GVHD, new drugs to treat acute and chronic GVHD and clinical trials testing new GVHD therapies.

Graft-versus-host disease (GVHD) frequently affects the gastrointestinal tract and liver after a stem cell transplant using donor cells (allogenic transplant). There are two types of GVHD: acute and chronic. This presentation discusses the incidence, symptoms, risk factors for each and treatment options.